WO2005072082B1 - Composes de 2-guanidinylimidazolidinedione: procedes de preparation et d'utilisation - Google Patents

Composes de 2-guanidinylimidazolidinedione: procedes de preparation et d'utilisation

Info

Publication number
WO2005072082B1
WO2005072082B1 PCT/US2004/038909 US2004038909W WO2005072082B1 WO 2005072082 B1 WO2005072082 B1 WO 2005072082B1 US 2004038909 W US2004038909 W US 2004038909W WO 2005072082 B1 WO2005072082 B1 WO 2005072082B1
Authority
WO
WIPO (PCT)
Prior art keywords
substituted
unsubstituted
compound
acyl
alkyl
Prior art date
Application number
PCT/US2004/038909
Other languages
English (en)
Other versions
WO2005072082A3 (fr
WO2005072082A2 (fr
Inventor
Ai J Lin
Quan Zhang
Jian Guan
Wilbur K Milhous
Original Assignee
Ai J Lin
Quan Zhang
Jian Guan
Wilbur K Milhous
Us Army Med Res Mat Command
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ai J Lin, Quan Zhang, Jian Guan, Wilbur K Milhous, Us Army Med Res Mat Command filed Critical Ai J Lin
Priority to EP04821254A priority Critical patent/EP1686990B1/fr
Publication of WO2005072082A2 publication Critical patent/WO2005072082A2/fr
Publication of WO2005072082A3 publication Critical patent/WO2005072082A3/fr
Publication of WO2005072082B1 publication Critical patent/WO2005072082B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des composés de 2-guanidinylimidazolidinedione représentés par la formule générale A ou B, où R1 et R2 représentent individuellement hydrogène, halogène, alkyle, alcoxyle, amino, alkylamino ou aralkyle, et où R3 représente alkyle, cycloalkyle, hétérocycloalkyle, acyle, aryle, hétéroaryle, alkylaryle, sulfonyle, alkylsulfonyle; des sels de ceux-ci acceptables sur le plan pharmaceutique; ainsi que des procédés de fabrication correspondants. Par ailleurs, l'invention concerne des procédés de traitement, de prévention ou d'inhibition de la malaria à l'aide des composés de 2-guanidinylimidazolidinedione, des compositions pharmaceutiques contenant les composés de 2-guanidinylimidazolidinedione ainsi que des kits.
PCT/US2004/038909 2003-11-21 2004-11-19 Composes de 2-guanidinylimidazolidinedione: procedes de preparation et d'utilisation WO2005072082A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP04821254A EP1686990B1 (fr) 2003-11-21 2004-11-19 Composes de 2-guanidinylimidazolidinedione: procedes de preparation et d'utilisation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52367003P 2003-11-21 2003-11-21
US60/523,670 2003-11-21

Publications (3)

Publication Number Publication Date
WO2005072082A2 WO2005072082A2 (fr) 2005-08-11
WO2005072082A3 WO2005072082A3 (fr) 2005-12-22
WO2005072082B1 true WO2005072082B1 (fr) 2006-05-11

Family

ID=34825868

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/038909 WO2005072082A2 (fr) 2003-11-21 2004-11-19 Composes de 2-guanidinylimidazolidinedione: procedes de preparation et d'utilisation

Country Status (3)

Country Link
US (1) US7101902B2 (fr)
EP (1) EP1686990B1 (fr)
WO (1) WO2005072082A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010051129A2 (fr) * 2008-10-03 2010-05-06 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research And Materiel Command Nouveaux dérivés d'imidazolidinedione comme agents antimalariques, leur préparation, et procédés d'utilisation
WO2010144101A1 (fr) * 2009-06-09 2010-12-16 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Quinoléine méthanols de nouvelle génération
WO2012149093A1 (fr) * 2011-04-26 2012-11-01 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF ARMY Dérivés de 2-guanidino-4-oxo-imidazoline en tant qu'agents antipaludiques, synthèse et procédés d'utilisation de ceux-ci
WO2012149097A2 (fr) * 2011-04-26 2012-11-01 The United States Of America, As Represented By The Secretary Of Army, Dérivés de guanidylimidazole et de guanidylimidazoline en tant qu'agents anti-malaria, leur synthèse et leurs procédés d'utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957936A (en) * 1989-02-01 1990-09-18 Nippon Zoki Pharmaceutical Co., Ltd. Glycocyamidine derivatives

Also Published As

Publication number Publication date
US20050148645A1 (en) 2005-07-07
US7101902B2 (en) 2006-09-05
EP1686990B1 (fr) 2012-09-19
EP1686990A4 (fr) 2009-06-03
EP1686990A2 (fr) 2006-08-09
WO2005072082A3 (fr) 2005-12-22
WO2005072082A2 (fr) 2005-08-11

Similar Documents

Publication Publication Date Title
MXPA04003610A (es) Analogos de himbacina como antagonistas del receptor de trombina.
AR051156A1 (es) Compuestos a base de bicicloheteroarilaminas como ligandos de los canales ionicos,usos de los mismos y composiciones farmaceuticas que los contienen
US6080860A (en) Methods of making ureas and guanidines including, terazosin, prazosin, doxazosin, tiodazosin, trimazosin, quinazosin and bunazosin (exemplary of 2-substituted quinazoline compounds), and meobentine, and bethanidine and intermediates therefor
JP2009515872A5 (fr)
ECSP055974A (es) Síntesis de cloruros de 4 amino-2-butenoil y su uso en la preparación de 3-ciano quinolinas
WO2006109075A3 (fr) Composes pharmaceutiques
CA2445344A1 (fr) Derives de composes heterocycliques et medicaments
KR960701000A (ko) 안트라닐산 유도체(anthranilic acid derivative)
WO2007051081B1 (fr) Procede et composes pour la preparation d'analogues de cc-1065
AR061847A1 (es) Derivados de pirimidina 2- amino -5- sustituida. como inhibidores de quinasas. composiciones farmaceuticas.
AR053405A1 (es) Derivados de urea sustituidas, composiciones farmaceuticas y metodos para el tratamiento de cardiopatias
RU2005117789A (ru) Производные 4,5-диарилтиазола в качестве лигандов св-1
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
KR900009598A (ko) 혈관평활근 이완작용을 가진 화합물과 그의 제조방법
KR840005131A (ko) N-헤테로시클로술포닐-n'-피리미닐 우레아 및 n-헤테로시클로술포닐-n-트리아지닐 우레아의 제조방법
DE69923300D1 (de) Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung
AR043673A1 (es) Compuestos heterociclicos inhibidores no nucleosidos de la transcriptasa inversa i, preparacion de los mismos, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento del sida
JO2425B1 (en) Method for manufacturing vinyl acetate acid derivatives
WO2001009090A3 (fr) Derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinoneses, leurs procedes de preparation et leur application a titre de medicaments
PL378201A1 (pl) Sposób farmaceutyczny oraz związki wytwarzane tym sposobem
KR860001074A (ko) 생물학적으로 활성인 질소함유 헤테로시클릭 화합물의 제조방법
WO2005072082B1 (fr) Composes de 2-guanidinylimidazolidinedione: procedes de preparation et d'utilisation
EP2088142A3 (fr) Dihydropyrimidines, leur procédé de préparation et leur utilisation.
WO2005063786A3 (fr) Procede de production de derives de fluorocytidine
AU2660300A (en) Substituted benzo(DE)isoquinoline-1,3-diones

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

B Later publication of amended claims

Effective date: 20051102

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2004821254

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004821254

Country of ref document: EP